Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of the American...
                   
drugs.com     May 22, 2008            

MILAN, Italy, May 21, 2008 - BioXell S.p.A. (SWX: BXLN) today presents the data from its successful Phase IIb trial of Elocalcitol in BPH (Benign Prostatic Hyperplasia) in a podium presentation at the American Urological Association Annual... ... MILAN, Italy, May 21,... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

The Road to Recovery from Prostate Cancer Begins in the OR

newswise.com     7 hrs ago   1 related          

Keywords OPEN, LAPAROSCOPIC, ROBOTIC, PROTATECTOMIES, SURGERY, SAMADI, MOUNT SINAI, DA VINCI, MINIMALLY INVASIVE, CANCER, HALL, ROBOT, ROBOTICS, BLADDER, SEXUAL FUNCTION, ONCOLOGY, UROLOGY Description Join the Mount Sinai...                

comments

11:30 PM (PT) - Female Urinary Incontinence

uwtv.org     10 hrs ago          

Millions of women are affected by urinary incontinence every year at a large cost to society in the form of medical treatments and incontinence pads. In this program, doctors present a novel and effective treatment for urinary...                

comments

                   

Watch for Dehydration when Playing Sports

newswise.com     15 hrs ago          

Dehydration occurs when your body takes in less water than you are using. While playing sports, it is easy for a child to lose track of their fluid intake and become dehydrated. Without proper hydration, your child could suffer...                

comments

                   

AHN - Experimental Drug Shrinks Prostrate Cancer Tumors, Increases Survival Chances

allheadlinenews.com     17 hrs ago   99 related          

Abiraterone, an experimental cancer drug under trial, has potential for shrinking prostate tumors at a faster rate and giving cancer patients double the chance of survival in 70 to 80 percent of patients with aggressive...                

comments (1)